Low Fructose Diet in Diabetes Type 2
Effects of Low Fructose Diet on Glycemic Control in Patients With Type 2 Diabetes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age of 70-40 years
- body mass index(BMI) between 18.5 and 27
- Type 2 diabetes People who only control their diabetes by using glucose lowering tablets Type 2 diabetes (1 to 10 years)
Exclusion Criteria:
- Pregnancy and lactation
- Thyroid gland disorders
- Kidney disease and inflammation
- Follow the weight loss regimen 6 months before starting the study
- Usage of fatty and fatty foods, fiber powder Vitamin A Mineral Supplements, Omega 3
- Taking glucocorticoid drugs and non-steroidal anti-inflammatory drugs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: intervention group
Eight weeks of low fructose diet with a maximum of 12 g of fructose
|
|
|
No Intervention: control group
Eight weeks of regular diabetic diet with a 15%pro 30%fat 55%CHO
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
fasting blood suger(FBS)
Time Frame: 8 weeks
|
8 weeks
|
|
Homeostatic model assessment and insulin resistance(HOMA-IR)
Time Frame: 8weeks
|
8weeks
|
|
insulin
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Blood pressure
Time Frame: 8 weeks
|
8 weeks
|
|
Triglyceride
Time Frame: 8 weeks
|
8 weeks
|
|
LDL-C
Time Frame: 8 weeks
|
8 weeks
|
|
HDL-C
Time Frame: 8 weeks
|
8 weeks
|
|
Total cholestrole
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 93567
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.